Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for LifeMD, Inc. (LFMD : NSDQ)
 
 • Company Description   
LifeMD Inc. is a telehealth company. It offers a full portfolio of direct-to-patient products and services. The company combines virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers. LifeMD Inc., formerly known as Conversion Labs, is based in NEW YORK.

Number of Employees: 232

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.13 Daily Weekly Monthly
20 Day Moving Average: 141,488 shares
Shares Outstanding: 30.80 (millions)
Market Capitalization: $65.60 (millions)
Beta: 1.01
52 Week High: $16.28
52 Week Low: $1.85
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.98% -6.76%
12 Week -40.17% -34.63%
Year To Date -44.96% -33.44%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
236 FIFTH AVENUE SUITE 400
-
NEW YORK,NY 10001
USA
ph: 866-351-5907
fax: -
cdeutsch@lifemd.com http://www.lifemd.com
 
 • General Corporate Information   
Officers
Justin Schreiber - Chief Executive Officer and Chairman
Marc Benathen - Chief Financial Officer
Maria Stan - Principal Accounting Officer
Naveen Bhatia - Director
Roberto Simon - Director

Peer Information
LifeMD, Inc. (CHCR)
LifeMD, Inc. (ESRX)
LifeMD, Inc. (MYDP)
LifeMD, Inc. (GBCS)
LifeMD, Inc. (LAXAF)
LifeMD, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 53216B104
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/11/22
Share - Related Items
Shares Outstanding: 30.80
Most Recent Split Date: 10.00 (0.20:1)
Beta: 1.01
Market Capitalization: $65.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.23 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.68 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/11/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 5.41
Price/Cash Flow: -
Price / Sales: 0.63
EPS Growth
vs. Year Ago Period: 34.21%
vs. Previous Quarter: 13.79%
Sales Growth
vs. Year Ago Period: 59.59%
vs. Previous Quarter: 5.93%
ROE
03/31/22 - -2,115.32
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -107.59
12/31/21 - -148.19
09/30/21 - -356.55
Current Ratio
03/31/22 - 1.15
12/31/21 - 1.97
09/30/21 - 0.71
Quick Ratio
03/31/22 - 1.11
12/31/21 - 1.90
09/30/21 - 0.63
Operating Margin
03/31/22 - -36.45
12/31/21 - -43.48
09/30/21 - -82.46
Net Margin
03/31/22 - -60.35
12/31/21 - -65.57
09/30/21 - -95.77
Pre-Tax Margin
03/31/22 - -60.47
12/31/21 - -66.02
09/30/21 - -98.17
Book Value
03/31/22 - 0.39
12/31/21 - 0.71
09/30/21 - -0.61
Inventory Turnover
03/31/22 - 13.23
12/31/21 - 11.09
09/30/21 - 10.85
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
 

Powered by Zacks Investment Research ©